Bridging Duchenne muscular dystrophy therapy from rhesus monkeys to patients. [PDF]
Guo W, Ji W, Chen Y.
europepmc +1 more source
Givinostat enhances antisense oligonucleotide efficacy in the <i>mdx52</i> model of Duchenne muscular dystrophy. [PDF]
Phongsavanh X +8 more
europepmc +1 more source
Phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons. [PDF]
Rovina D +14 more
europepmc +1 more source
Antisense oligonucleotide selection scheme for rare Duchenne muscular dystrophy mutations: Application to <i>DMD</i> exon 16 skipping. [PDF]
Geoffroy-Guiraud M +8 more
europepmc +1 more source
Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophy. [PDF]
Stenler S +8 more
europepmc +1 more source
Congenital Clubfoot as an Early Manifestation of Duchenne Muscular Dystrophy? [PDF]
Kenis V +4 more
europepmc +1 more source
Clinical, pathological, and genetic characteristics of 23 DMD patients in northern China. [PDF]
Bu Y +7 more
europepmc +1 more source
Exploring Dystrophin Expression and Mutations in the <i>DMD</i> and Dystrophin-Glycoprotein Complex Genes as Prognostic Factors in Leiomyosarcomas. [PDF]
Salazar J +15 more
europepmc +1 more source
Microdystrophins partially rescue deficits of Duchenne muscular dystrophy iPSC-cardiomyocytes. [PDF]
Keegan AR +14 more
europepmc +1 more source
Dystrophin-Deficient Muscular Dystrophy in a Jack Russell Terrier With a Large Deletion in the Canine DMD Gene. [PDF]
Royaux E +4 more
europepmc +1 more source

